SUVN-502 dimesylate
CAS: 1791396-46-7
Ref. 3D-RWC39646
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
SUVN-502 dimesylate is a pharmaceutical combination that contains the acetylcholinesterase inhibitor donepezil and the 5-HT6 receptor antagonist pruvincamine. It is used for the treatment of dementia symptoms, with an effective dose of 40 mg/day. SUVN-502 dimesylate has a dual mechanism of action by inhibiting acetylcholinesterase and antagonizing 5-HT6 receptors. The 5-HT6 receptor is involved in memory consolidation and learning, as well as cognition. This drug may be useful in treating people who have moderate to severe dementia, particularly if they are already taking donepezil or other acetylcholinesterase inhibitors.
Chemical properties
Technical inquiry about: 3D-RWC39646 SUVN-502 dimesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
